soul trial oral semaglutide cardiovascular outcomes 2024 results mace reduction The (Semaglutide Trial) was a randomized, double-blind, placebo-controlled cardiovascular outcomes trial that enrolled 9,650 patients aged 50 years or older with Frontiers | Effects of subcutaneous

Patients at high risk of colon cancer should undergo rigid proctoscopy, flexible sigmoidoscopy, or colonoscopy

Overall, while weight loss medications can significantly aid in reducing total body weight and lowering the risk of serious health problems, they should be used responsibly and as part of a broader strategy for treating obesity and related conditions

In this study, two distinct patient populations were analyzed: Those with type 2 diabetes were provided Ozempic, while patients with obesity were prescribed Wegovy

Exogenous GLP-1 has the potential to normalize fasting and PPG levels in patients with T2D

A practical safety consideration is the risk of dosing confusion when both medications are administered weekly

A balanced diet emphasizing whole grains, lean proteins, vegetables, and healthy fats supports both glycemic control and weight management